Medical Devices: Page 119


  • Hologic to launch 2nd coronavirus test amid broader sales slide

    The molecular diagnostics business posted its best growth rate in eight years, but the breast health and surgical segments slowed as a result of postponed elective surgeries.

    By April 30, 2020
  • Teleflex yanks guidance as coronavirus craters key product

    Sales of UroLift plummeted 64% in the last two weeks of March, wiping out an important growth driver.

    By April 30, 2020
  • Close up of hand touching smartwatch with health app on the screen. Explore the Trendlineâž”
    Image attribution tooltip
    Sitthiphong via Getty Images
    Image attribution tooltip
    Trendline

    Medical device industry continues to turn to AI

    While the industry continues to embrace artificial intelligence, there are still questions about how the new technologies need to be regulated and if they are effective.

    By MedTech Dive staff
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    Baxter cites 'extraordinary' Q1 demand from customers fighting coronavirus

    Revenues grew 6% to $2.8 billion thanks to growth across all six of the company's global business units and three geographic segments.

    By April 30, 2020
  • Image attribution tooltip
    Getty Images
    Image attribution tooltip

    AdvaMed pushes US to lift tariffs on Chinese imports of COVID-19 devices

    The trade group wants indefinite exemptions for imaging components and devices used in ventilators, among other items. It also floated a compromise: re-imposing them one year after the pandemic passes.

    By April 30, 2020
  • Boston Scientific sees April sales cut in half amid coronavirus

    One potential area of optimism: two-thirds of the device giant's business comes from procedures in outpatient settings like ambulatory surgery centers and physicians offices, which the company expects will resume operations sooner.

    By Maria Rachal • April 29, 2020
  • Dexcom's hospital strategy accelerates, but next-gen iCGM path slows

    The continuous glucose monitor manufacturer recorded its highest number of new users ever during the first quarter as it topped Wall Street revenue estimates by around $50 million, weathering a dip in business in late March.

    By Maria Rachal • April 29, 2020
  • GE reducing healthcare headcount in $700M cost-cutting drive

    The cuts come as the conglomerate seeks to adapt its business to volatility and pressures created by the global coronavirus pandemic.

    By April 29, 2020
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA says 18 deaths linked to intragastric weight loss balloons

    The liquid-filled devices manufactured by Apollo Endosurgery have generated more than 230 adverse event reports to the agency, but regulators still believe they can be an effective treatment for some patients.

    By April 28, 2020
  • Novocure shares data from post-approval brain cancer device trial

    As part of the virtual AACR 2020, researchers said data show use of a Novocure technology resulted in longer median overall survival than occurred with best standard of care chemotherapy.

    By April 28, 2020
  • Image attribution tooltip
    Jacob Bell / BioPharma Dive
    Image attribution tooltip

    FDA tweaks electronic filing guidance amid heavy use of emergency authorization pathway

    After taking paper out of the medical device premarket application process in December, the agency's updated guidance features a new option for companies seeking emergency use authorization, common during the pandemic.

    By April 28, 2020
  • A picture of the exterior of the US Department of Health and Human Services. In front of the building is a black sign designating the building's name.
    Image attribution tooltip
    Alex Wong via Getty Images
    Image attribution tooltip

    CMS hits pause on speeding Medicare payments, including for DME suppliers

    The Trump administration is suspending accelerated Medicare pay to doctors and durable medical equipment suppliers, and is re-evaluating hospital requests, after another round of emergency funding was signed into law Friday.

    By Rebecca Pifer • April 27, 2020
  • Edwards sees 14% sales bump in Q1, but near-term TAVR prospects grim

    Results beat Wall Street's expectations on momentum in the transcatheter aortic valve business at the start of the first quarter. But CEO Mike Mussallem warned that since then: "We've watched the system really screech to a halt."

    By April 24, 2020
  • It's official: EU finalizes 1-year MDR delay

    The European Commission listed a 13th notified body designated for Medical Device Regulation-related work in its official database Saturday, the first new firm announced in over a month and the fifth based in Germany.

    By Maria Rachal • Updated April 27, 2020
  • FDA moves to boost access to imaging systems during pandemic

    The agency is allowing devices to be modified for portable use to enable imaging outside of hospitals in an effort to potentially slow the spread of COVID-19. 

    By April 24, 2020
  • Image attribution tooltip
    Jacob Bell
    Image attribution tooltip

    FDA grants breakthrough status to heart failure, stent graft tech

    The newly disclosed breakthrough device designations follow ones awarded to a speech therapy app and a treatment for stable vertebral compression fractures in recent weeks.

    By April 24, 2020
  • Image attribution tooltip
    Fotolia
    Image attribution tooltip

    Senseonics averts cash crunch with $20M loan but future remains grim

    The much-needed funds buy the company some time to look for a potential acquirer and secure FDA approval of a 180-day version of its implantable continuous glucose monitor. 

    By April 23, 2020
  • MedTech Europe pushes for IVDR delay as MDR hold nears finish line

    The trade group warned that "even before the COVID-19 pandemic, very little progress had been achieved" to get the In Vitro Diagnostic Regulation ready, which it said altogether warrants at least a 12-month delay.

    By April 23, 2020
  • Medtronic sees US business fall 60% amid pandemic response

    The subset of devices suddenly seeing higher demand are mostly low-margin businesses, leading the medtech giant to brace investors for a hit to earnings during next month's quarterly report.​

    By Maria Rachal • April 22, 2020
  • ResMed to get biggest bang out of HHS ventilator contracts, analysts predict

    Medtronic and Hillrom may see limited gains from their smaller deals, but â€‹ResMed’s contract could add a 2.7% bump to growth in the fourth quarter, Needham analysts noted.

    By April 21, 2020
  • Image attribution tooltip
    Courtesy of Nationwide Children's Hospital
    Image attribution tooltip

    CMS, surgeons group offer paths forward to resume elective procedures

    Johnson & Johnson, Abbott and Intuitive Surgical are among the device makers that reported the widespread deprioritization of surgeries during the pandemic dented sales at the end of the first quarter.  

    By April 20, 2020
  • Philips to invest $109M as COVID-19 drives connected care order growth

    CEO Frans van Houten said sourcing component parts from affected suppliers has been a challenge amid increasing demand for ventilators, patient monitors and certain diagnostic devices.

    By April 20, 2020
  • FDA device review times could get iffy, agency chief says

    "It is difficult to speculate on what the exact impact will be on incoming submissions moving forward," Commissioner Stephen Hahn said in an update on hitting MDUFA goals amid the constraints of the public health emergency.

    By Maria Rachal • April 17, 2020
  • EU MDR delay clears Parliament, enters final stages

    During a plenary focused on combating the coronavirus pandemic, the European Parliament on Friday voted overwhelmingly in favor of pushing back the regulatory overhaul. A few steps remain.

    By April 17, 2020
  • GE, Ford get $336M HHS contract for 50K lower-cost ventilators

    The latest deal works out to about $6,720 per ventilator. GE's roughly $64 million contract for 2,410 ventilators detailed earlier this week works out to a little more than $26,000 per device. 

    By April 17, 2020
  • Pandemic drives US da Vinci robot use down 65%

    A major shift to leasing the robotic surgery systems and other alternative financing arrangements is on the horizon, Intuitive predicts, amid early signs cash-strapped hospitals are deferring big purchases in the wake of COVID-19.

    By April 17, 2020